Home   »  TRADE TOPICS  »  Prescription Drugs  »  Public Leadership

Letter from AZ State Sen. Meg Burton Cahill and CT State Representative Kevin Ryan to the US House Ways and Means Subcommittee on Trade

March 18th, 2007

The Honorable Sander Levin
Chairman, Subcommittee on Trade
House and Ways and Means Committee
Washington, DC

Dear Chairman Levin and members of the Subcommittee on Trade:

We write to express our strong opposition to USTRís efforts to use provisions in the proposed US-Korea Free Trade Agreement (FTA) to undermine the use of drug formularies for managing prescription drug costs. On behalf of states across the nation that use similar formularies to contain drug costs for Medicaid and other programs that may be affected by the FTA language, we request you to seek assurances from USTR in the upcoming hearing on the US-Korea FTA negotiations that USTR will not include limitations on cost-cutting drug formularies in any final agreement...

Unless otherwise expressly stated, all original material of whatever nature created by the Forum on Democracy & Trade website is licensed under a Creative Commons License. Privacy Statement | Sitemap